Ardent Health, Inc.

What they do

Ardent operates acute care hospitals, ambulatory facilities, and physician practices across Texas, Oklahoma, New Mexico, New Jersey, Idaho, and Kansas. It provides general and specialty services (cardiology, oncology, orthopedics, etc.) through a network that includes 188 clinics, 45 urgent care centers, and over 2,000 providers. The company uses a joint-venture model with academic medical centers and not-for-profit systems.

Revenue drivers

• Net patient service revenue — Primary revenue source; second quarter 2026 revenue was $1.62 billion, with per-admission revenue down 3.9% year-over-year.
• Inpatient and outpatient surgeries — Total surgeries were 31,755 in Q2 2026, down 2.9% year-over-year, with inpatient surgeries down 7.5%.
• Adjusted admissions — Adjusted admissions grew 2.5% year-over-year to 89,326 in Q2 2026, partially offsetting the decline in surgical volumes.

Recent performance

For Q2 2026, total revenue declined 1.4% year-over-year to $1.62 billion, and net income attributable to Ardent was $17 million ($0.12 per diluted share), down from $73 million a year earlier. Adjusted EBITDA fell 32.3% to $115 million, impacted by lower surgeries and a prior-year benefit from the New Mexico state directed payment program. Operating cash flow increased 67% year-over-year to $197 million. Full-year 2025 revenue was $6.32 billion with net income of $135.8 million.

Strategy

Management emphasizes sharpening operational execution, focusing on staffing, contracting, capital allocation, standardization, and accountability. The IMPACT program is expected to deliver at least $70 million in savings in 2026, up from $55 million previously. The company is accelerating ambulatory and physician alignment initiatives to expand consumer access and support value-based care. It also continues to pursue joint ventures and acquisitions to grow market share.

Risks

• Medicare/Medicaid changes — Reductions or changes in government programs, including Medicaid supplemental payments, could materially reduce revenues.
• Commercial payor pressure — Lower reimbursement rates, increased denials, or payment delays from commercial payors could hurt earnings.
• Physician and nurse shortages — Inability to recruit and retain quality physicians and nurses could increase labor costs and disrupt operations.
• Information technology disruptions — Security threats or system failures have adversely affected and could again disrupt relationships, and result in legal liabilities.

Outlook

Management reaffirmed full-year 2026 guidance: total revenue of $6.4 billion to $6.7 billion and Adjusted EBITDA of $485 million to $535 million. They expect volumes to improve after an intra-quarter update in early June, and they are implementing mitigation plans for the One Big Beautiful Bill Act and tariff impacts. The company is factoring in a lower volume outlook but remains confident in its earnings guidance.